跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
RAPIBLYK landiolol hydrochloride 300 mg powder for injection vial - TGA Drug Approval Details
Approvals
/
TGA
/
RAPIBLYK landiolol hydrochloride 300 mg powder for injection vial
Approved
STANDARD
RAPIBLYK landiolol hydrochloride 300 mg powder for injection vial
Phebra Pty Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
Jun 19, 2025
Approval ID
077572d8a0dddc6b
Company
Phebra Pty Ltd
Type
Standard
Approval Details
Approval Id
077572d8a0dddc6b
Product Name
RAPIBLYK landiolol hydrochloride 300 mg powder for injection vial
Artg Id
463165
Artg Name
RAPIBLYK landiolol hydrochloride 300 mg powder for injection vial
Sponsor
Phebra Pty Ltd
Company Detail Path
/organization/phebra-pty-ltd
Artg Date
2025-06-13
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
RE
Active Ingredients
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
Jun 19, 2025
Approval ID
077572d8a0dddc6b
Type
Standard
Back to TGA Approvals